ICU Medical, Inc.
US ˙ NasdaqGS ˙ US44930G1076

SecurityICUI / ICU Medical, Inc.
InstitutionQuantinno Capital Management LP
Latest Disclosed Ownership215,490 shares
Latest Disclosed Value $ 27,830,534
Quantinno Capital Management LP reports 22.68% decrease in ownership of ICUI / ICU Medical, Inc.

On May 15, 2026 - Quantinno Capital Management LP filed a 13F-HR form disclosing ownership of 215,490 shares of ICU Medical, Inc. (US:ICUI) valued at $27,830,534 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 278,707 shares of ICU Medical, Inc.. This represents a change in shares of -22.68% during the quarter. The current value of the position is $29,076,066 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ICU MED COM 44930G107 215,490 -63,217 -22.68 27,831 -30.01 0.0464
2026-02-17 2025-12-31 13F ICU MED COM 44930G107 278,707 26,258 10.40 39,763 31.30 0.0799
2025-11-14 2025-09-30 13F ICU MED COM 44930G107 252,449 117,307 86.80 30,284 69.57 0.0826
2025-08-14 2025-06-30 13F ICU MED COM 44930G107 135,142 76,352 129.87 17,859 118.78 0.0771
2025-05-12 2025-03-31 13F ICU MED COM 44930G107 58,790 12,842 27.95 8,164 14.50 0.0532
2025-02-14 2024-12-31 13F ICU MED COM 44930G107 45,948 -389 -0.84 7,130 -15.56 0.0701
2024-11-14 2024-09-30 13F ICU MED COM 44930G107 46,337 7,174 18.32 8,444 81.57 0.1098
2024-08-14 2024-06-30 13F ICU MED COM 44930G107 39,163 8,679 28.47 4,651 42.11 0.0836
2024-05-14 2024-03-31 13F ICU MED COM 44930G107 30,484 24,758 432.38 3,272 473.03 0.0711
2024-02-14 2023-12-31 13F ICU MED COM 44930G107 5,726 2,601 83.23 571 53.49 0.0200
2023-11-14 2023-09-30 13F ICU MED COM 44930G107 3,125 3,125 372 0.0169
2022-08-15 2022-06-30 13F ICU MED COM 44930G107 0 -4,095 -100.00 0 -100.00
2022-05-12 2022-03-31 13F ICU MED COM 44930G107 4,095 1,460 55.41 912 45.92 0.1391
2022-02-14 2021-12-31 13F ICU MED COM 44930G107 2,635 1,622 160.12 625 164.83 0.1132
2021-11-15 2021-09-30 13F ICU MED COM 44930G107 1,013 1,013 236 0.2635
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.